General physicians and prescribing pattern in Isfahan, Iran

Oman Medical Journal

Volumn 26, Issue 3, 2011, Pages 205-206

  Safaeian, Leila ^a   Mahdanian, Ali Reza ^a   Hashemi Fesharaki, Mansoor ^a   Salami, Soolmaz ^a   Kebriaee Zadeh, Javad ^a   Sadeghian, Gholam Hossein ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858202377     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2011.50     Document Type: Note

References (10)

1. De Vries Th PG, Henning RH, Hogerzeil HV, Fresle DA. Guide to good prescribing. WHO/Geneva: World Health Organization, 1994.
2. WHO. How to investigate drug use in health facilities (selected drug use indicators). Geneva: World Health Organization, 1993.
3. Soleymani F, Valadkhani M, Dinarvand R. Challenges and achievements of promoting rational use of drugs in Iran. Iran J Public Health 2009;38(1):166-168.
4. Hogerzeil HV, Walker GJ, Sallami AO, Fernando G. Impact of an essential drugs programme on availability and rational use of drugs. Lancet 1989 Jan;1(8630):141-142.
5. Hamadeh GN, Dickerson LM, Saab BR, Major SC. Common prescriptions in ambulatory care in Lebanon. Ann Pharmacother 2001 May;35(5):636-640.
6. Otoom S, Batieha A, Hadidi H, Hasan M, Al-Saudi K. Evaluation of drug use in Jordan using WHO prescribing indicators. East Mediterr Health J 2002 Jul-Sep;8(4-5):537-543.
7. Roumie CL, Halasa NB, Grijalva CG, Edwards KM, Zhu Y, Dittus RS, et al. Trends in antibiotic prescribing for adults in the United States-1995 to 2002. J Gen Intern Med 2005 Aug;20(8):697-702.
8. Hogerzeil HV, Bimo B, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, et al. Field tests for rational drug use in twelve developing countries. Lancet 1993 Dec;342(8884):1408-1410.
9. Janjua NZ, Akhtar S, Hutin YJ. Injection use in two districts of Pakistan: implications for disease prevention. Int J Qual Health Care 2005 Oct;17(5):401-408.
10. Imam AP, Halpern GM. Uses, adverse effects of abuse of corticosteroids. Part I. Allergol Immunopathol (Madr) 1994 Nov-Dec;22(6):250-260.